JPS562962A - Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done - Google Patents

Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done

Info

Publication number
JPS562962A
JPS562962A JP7790580A JP7790580A JPS562962A JP S562962 A JPS562962 A JP S562962A JP 7790580 A JP7790580 A JP 7790580A JP 7790580 A JP7790580 A JP 7790580A JP S562962 A JPS562962 A JP S562962A
Authority
JP
Japan
Prior art keywords
glycolic acid
acid oxidase
55done
oxidase inhibitor
diones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7790580A
Other languages
English (en)
Inventor
Jiee Kuragoo Jiyuniya Edowaado
Esu Ruunii Kureransu
Daburiyu Aaru Uiriamuzu Heidon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS562962A publication Critical patent/JPS562962A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP7790580A 1979-06-11 1980-06-11 Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done Pending JPS562962A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/047,413 US4256758A (en) 1979-06-11 1979-06-11 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Publications (1)

Publication Number Publication Date
JPS562962A true JPS562962A (en) 1981-01-13

Family

ID=21948829

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7790580A Pending JPS562962A (en) 1979-06-11 1980-06-11 Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done

Country Status (10)

Country Link
US (1) US4256758A (ja)
EP (1) EP0021228B1 (ja)
JP (1) JPS562962A (ja)
AT (1) ATE1501T1 (ja)
DE (1) DE3060801D1 (ja)
DK (1) DK249680A (ja)
ES (1) ES492310A0 (ja)
GR (1) GR68727B (ja)
IE (1) IE49902B1 (ja)
PT (1) PT71368B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816528U (ja) * 1981-07-25 1983-02-01 三菱重工業株式会社 液位計

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428959A (en) * 1980-04-04 1984-01-31 Merck & Co., Inc. 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
US4634717A (en) * 1984-05-01 1987-01-06 Merck & Co., Inc. Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
US4596821A (en) * 1984-05-01 1986-06-24 Merck & Co., Inc. Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4605664A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treatment of grey matter edema
US4604403A (en) * 1984-05-01 1986-08-05 Merck & Co., Inc. Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4605663A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, for treatment of grey matter edema
ATE118536T1 (de) * 1988-10-29 1995-03-15 Cadbury Schweppes Plc Netzmittel.
US6353128B1 (en) * 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070078121A1 (en) 2004-12-23 2007-04-05 Flynn Daniel L Enzyme modulators and treatments
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
EA200970700A1 (ru) 2007-04-20 2010-02-26 ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Ингибиторы киназы, пригодные для лечения миелопролиферативных заболеваний и других пролиферативных заболеваний
MX2011004535A (es) 2008-10-29 2011-11-18 Deciphera Pharmaceuticals Llc Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas.
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
BR112015014349A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente
DE102013213217A1 (de) 2013-07-05 2015-01-08 Bayerische Motoren Werke Aktiengesellschaft Schließbaugruppe für einen Gepäckkoffer
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
EP3386967A4 (en) * 2015-12-07 2020-03-25 Wake Forest University Health Sciences COMBINATIONS FOR THE TREATMENT OF KIDNEY CALCULATIONS
CN107805209B (zh) * 2016-09-09 2020-11-10 中国石化扬子石油化工有限公司 一种对二乙酰苯酰胺化制备2-(4-氨基甲酰基甲基-苯基)-乙酰胺的方法
CN111818915B (zh) 2018-01-31 2024-05-24 德西费拉制药有限责任公司 治疗胃肠道间质瘤的组合疗法
KR20220045189A (ko) 2019-08-12 2022-04-12 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양을 치료하는 방법
TW202122082A (zh) 2019-08-12 2021-06-16 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
EP4327827A3 (en) 2019-12-30 2024-05-29 Deciphera Pharmaceuticals, LLC Amorphous kinase inhibitor formulations and methods of use thereof
JP2023509628A (ja) 2019-12-30 2023-03-09 デシフェラ・ファーマシューティカルズ，エルエルシー １－（４－ブロモ－５－（１－エチル－７－（メチルアミノ）－２－オキソ－１，２－ジヒドロ－１，６－ナフチリジン－３－イル）－２－フルオロフェニル）－３－フェニル尿素の組成物
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184475A (en) * 1961-09-15 1965-05-18 Monsanto Co Maleimides, maleamides and fumaramides
US3183245A (en) * 1963-01-04 1965-05-11 Parke Davis & Co Process for the production of alpha-methyl-alpha-phenyl-beta-ethylsuccinimide
DE1445664A1 (de) * 1963-07-04 1969-11-27 Klinke Desitin Werk Verfahren zur Herstellung von alpha,alpha-disubstituierten Succinimiden
CH445487A (de) * 1963-08-05 1967-10-31 Calanda Stiftung Verfahren zur Darstellung cyclischer Imide
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
US3317390A (en) * 1965-07-27 1967-05-02 American Cyanamid Co Compositions having cns depressant activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816528U (ja) * 1981-07-25 1983-02-01 三菱重工業株式会社 液位計

Also Published As

Publication number Publication date
ES8105283A1 (es) 1981-05-16
US4256758A (en) 1981-03-17
PT71368A (en) 1980-07-01
EP0021228B1 (en) 1982-09-01
GR68727B (ja) 1982-02-10
ATE1501T1 (de) 1982-09-15
EP0021228A1 (en) 1981-01-07
IE801178L (en) 1980-12-11
IE49902B1 (en) 1986-01-08
DE3060801D1 (en) 1982-10-28
ES492310A0 (es) 1981-05-16
PT71368B (en) 1981-10-21
DK249680A (da) 1980-12-12

Similar Documents

Publication Publication Date Title
JPS562962A (en) Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done
GR70200B (ja)
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
NO893142L (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ZA806786B (en) 4-substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
IL89901A0 (en) Strobilurine derivatives
NO893326D0 (no) Fremgangsmaate for noeytralisering av svovelsyre inneholdende sinkioner.
IT8422394A0 (it) Procedimento per il trattamento e/o l'immagazzinamento di residui industriali.
NO884635D0 (no) Fremgangsmaate for behandling av most.
DE3161869D1 (en) A pharmaceutical composition for treating hypertension containing l-alpha-methyl-3,4-dihydroxyphenylalanine and salicylamide
NO166008C (no) Fremgangsmaate for behandling av peroxydblekeavluter.
AR245225A1 (es) Composiciones para el tratamiento de cuero.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
AR244206A1 (es) Compuesto de tetrahidroftalimida, procedimiento para obtenerlos, composiciones herbicidas que los contienen y la feniltetrahidroftalimida de aplicacion exclusiva en dicho procedimiento.